Luciana Previato De Almeida, PhD
About Luciana Previato De Almeida, PhD
Luciana Previato De Almeida, PhD, is an Assistant Staff Scientist at the Oklahoma Medical Research Foundation, where she investigates the role of the Rmi 2 protein in meiosis and its interaction with BLM protein in mice.
Work at Oklahoma Medical Research Foundation
Luciana Previato De Almeida, PhD, has been serving as an Assistant Staff Scientist at the Oklahoma Medical Research Foundation since 2019. In this role, she focuses on genetic research, utilizing advanced techniques such as CRISPR Cas9, siRNA, and ChIP seq. Prior to her current position, she worked as a Postdoctoral Fellow at the same institution from 2016 to 2019, where she contributed to various research projects, including stem cell therapy for Duchenne's muscular dystrophy in a mouse model.
Education and Expertise
Luciana Previato De Almeida earned her Doutorado from Faculdade de Medicina de Ribeirao Preto USP, completing her studies from 2008 to 2012. She also obtained her Mestrado in Immunology from the same institution between 2005 and 2008. Earlier, she studied Pharmacy and Biochemistry at the School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, achieving her Bachelor of Pharmacy in 2003. Her expertise includes gene-editing techniques such as zinc-finger nucleases and meganucleases, which she gained during her studies at Laval University in Quebec, Canada.
Research Focus
Luciana Previato De Almeida investigates the role of the protein Rmi 2 in meiosis and its interaction with BLM protein in mice, which is related to chromosome segregation defects. Her research also includes the role of B lymphocytes in T cell memory generation following DNA vaccine administration, which she studied during her master's program. Additionally, she has experience in generating and genotyping transgenic mice models for research purposes.
Previous Research Experience
Before her current role, Luciana Previato De Almeida worked on intracellular trafficking in neurons during her first post-doctoral research in Brazil. Her doctoral research involved stem cell therapy for Duchenne's muscular dystrophy, focusing on a mouse model. This diverse research background has contributed to her comprehensive understanding of genetic and immunological processes.